PuraPharm Corp. Ltd. (HK:1498) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
PuraPharm Corp. Ltd. has announced a change in its auditor, replacing Ernst & Young with BDO Limited, due to more competitive proposals that promise enhanced corporate governance and cost-effectiveness. This shift follows EY’s resignation over a disagreement on audit fees for the upcoming fiscal year. The company assures that the transition will not impact its annual audit for FY2024.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.